NCT00003870View on ClinicalTrials.gov

Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 1999

Primary Completion Date

November 30, 2001

Study Completion Date

November 30, 2001

Conditions
Leukemia
Interventions
DRUG

cyclophosphamide

DRUG

methotrexate

PROCEDURE

allogeneic bone marrow transplantation

RADIATION

iodine I 131 monoclonal antibody BC8

RADIATION

radiation therapy

Trial Locations (2)

98109

Fred Hutchinson Cancer Research Center, Seattle

98195-6043

University of Washington Medical Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER